The supplementary IHC assay revealed that both tumor cell types were positive for GATA-3 but negative for estrogen and progesterone receptors (ER and PR), despite the slight difference in the intensity of expression of GATA-3 in two tumors. The gene discussed is PGR; the disease is neoplasm.